Proof of Usefulness Report

AMPLY Discovery

Analysis completed on 1/10/2026

+288
Proof of Usefulness Score
Gaining Momentum

The project 'AMPLY Discovery' is a legitimate and promising biotech spin-out from Queen's University Belfast, utilizing AI and synthetic biology for drug discovery (specifically anti-infectives and oncology). External verification confirms significant traction, including a $1.75M seed round (2025) and £1.6M+ in grants. However, the submission itself was of extremely poor quality (user 'BlazeStorm'), containing false claims ('most people have used my product') and vague data. The score reflects the high potential and verified deep-tech utility of the company, penalized heavily for the low-quality submission and false user metrics.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+23
Audience Reach Impact+14
Technical Innovation+13
Evidence Of Traction+8
Market Timing Relevance+9
Functional Completeness+0
Subtotal+68
Usefulness Multiplierx1.05
Final Score+288

Project Details

Description
AMPLY Discoveryis in the Life Sciences Tech Industry
Audience Reach
everyone
Target Users
everyone
Technologies
Biotechnology, Healthcare Tech
Traction Evidence
most people have used my product

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline